KRAS and cancer: Although it is early to evaluate the benefits of the mentioned approaches, the exploration of these opportunities could result in overcoming KRAS-resistance mechanisms and the forthcoming results are expected to bring new therapeutic benefit for patients with KRAS-mutant cancer.